In vitro toxic evaluation of two gliptins and their main impurities of synthesis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/205991 |
Resumo: | Background: The presence of impurities in some drugs may compromise the safety and efficacy of the patient’s treatment. Therefore, establishing of the biological safety of the impurities is essential. Diabetic patients are predisposed to tissue damage due to an increased oxidative stress process; and drug impurities may contribute to these toxic effects. In this context, the aim of this work was to study the toxicity, in 3 T3 cells, of the antidiabetic agents sitagliptin, vildagliptin, and their two main impurities of synthesis (S1 and S2; V1 and V2, respectively). Methods: MTT reduction and neutral red uptake assays were performed in cytotoxicity tests. In addition, DNA damage (measured by comet assay), intracellular free radicals (by DCF), NO production, and mitochondrial membrane potential (ΔψM) were evaluated. Results: Cytotoxicity was observed for impurity V2. Free radicals generation was found at 1000 μM of sitagliptin and 10 μM of both vildagliptin impurities (V1 and V2). A decrease in NO production was observed for all vildagliptin concentrations. No alterations were observed in ΔψM or DNA damage at the tested concentrations. Conclusions: This study demonstrated that the presence of impurities might increase the cytotoxicity and oxidative stress of the pharmaceutical formulations at the concentrations studied. |
id |
UFRGS-2_172bddce7bb83e67ab9a9e8d70d66c2c |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/205991 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Giordani, Camila Ferrazza AlvesCampanharo, Sarah ChagasWingert, Nathalie RibeiroBueno, Lívia MaronesiManoel, Joanna WittckindCosta, Bárbara Souza daCattani, Shanda AparecidaArbo, Marcelo DutraGarcia, Solange CristinaGarcia, Cassia VirginiaVolpato, Nadia MariaSchapoval, Elfrides Eva SchermanSteppe, Martin2020-02-15T04:20:24Z20192050-6511http://hdl.handle.net/10183/205991001112186Background: The presence of impurities in some drugs may compromise the safety and efficacy of the patient’s treatment. Therefore, establishing of the biological safety of the impurities is essential. Diabetic patients are predisposed to tissue damage due to an increased oxidative stress process; and drug impurities may contribute to these toxic effects. In this context, the aim of this work was to study the toxicity, in 3 T3 cells, of the antidiabetic agents sitagliptin, vildagliptin, and their two main impurities of synthesis (S1 and S2; V1 and V2, respectively). Methods: MTT reduction and neutral red uptake assays were performed in cytotoxicity tests. In addition, DNA damage (measured by comet assay), intracellular free radicals (by DCF), NO production, and mitochondrial membrane potential (ΔψM) were evaluated. Results: Cytotoxicity was observed for impurity V2. Free radicals generation was found at 1000 μM of sitagliptin and 10 μM of both vildagliptin impurities (V1 and V2). A decrease in NO production was observed for all vildagliptin concentrations. No alterations were observed in ΔψM or DNA damage at the tested concentrations. Conclusions: This study demonstrated that the presence of impurities might increase the cytotoxicity and oxidative stress of the pharmaceutical formulations at the concentrations studied.application/pdfengBMC pharmacology and toxicology. London. Vol. 20, Supl. 1 (2019), 82, [9 p.]FarmáciaFosfato de sitagliptinaVildagliptinaCitotoxicidadeEstresse oxidativoIn vitro toxic evaluation of two gliptins and their main impurities of synthesisEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001112186.pdf.txt001112186.pdf.txtExtracted Texttext/plain35933http://www.lume.ufrgs.br/bitstream/10183/205991/2/001112186.pdf.txt25e873f075c0b74c77ccaa7e382cd44cMD52ORIGINAL001112186.pdfTexto completo (inglês)application/pdf1905667http://www.lume.ufrgs.br/bitstream/10183/205991/1/001112186.pdf126134e4a541d8a3ee8e1bc6fd2258a7MD5110183/2059912020-02-16 04:16:39.835098oai:www.lume.ufrgs.br:10183/205991Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2020-02-16T07:16:39Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
In vitro toxic evaluation of two gliptins and their main impurities of synthesis |
title |
In vitro toxic evaluation of two gliptins and their main impurities of synthesis |
spellingShingle |
In vitro toxic evaluation of two gliptins and their main impurities of synthesis Giordani, Camila Ferrazza Alves Farmácia Fosfato de sitagliptina Vildagliptina Citotoxicidade Estresse oxidativo |
title_short |
In vitro toxic evaluation of two gliptins and their main impurities of synthesis |
title_full |
In vitro toxic evaluation of two gliptins and their main impurities of synthesis |
title_fullStr |
In vitro toxic evaluation of two gliptins and their main impurities of synthesis |
title_full_unstemmed |
In vitro toxic evaluation of two gliptins and their main impurities of synthesis |
title_sort |
In vitro toxic evaluation of two gliptins and their main impurities of synthesis |
author |
Giordani, Camila Ferrazza Alves |
author_facet |
Giordani, Camila Ferrazza Alves Campanharo, Sarah Chagas Wingert, Nathalie Ribeiro Bueno, Lívia Maronesi Manoel, Joanna Wittckind Costa, Bárbara Souza da Cattani, Shanda Aparecida Arbo, Marcelo Dutra Garcia, Solange Cristina Garcia, Cassia Virginia Volpato, Nadia Maria Schapoval, Elfrides Eva Scherman Steppe, Martin |
author_role |
author |
author2 |
Campanharo, Sarah Chagas Wingert, Nathalie Ribeiro Bueno, Lívia Maronesi Manoel, Joanna Wittckind Costa, Bárbara Souza da Cattani, Shanda Aparecida Arbo, Marcelo Dutra Garcia, Solange Cristina Garcia, Cassia Virginia Volpato, Nadia Maria Schapoval, Elfrides Eva Scherman Steppe, Martin |
author2_role |
author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Giordani, Camila Ferrazza Alves Campanharo, Sarah Chagas Wingert, Nathalie Ribeiro Bueno, Lívia Maronesi Manoel, Joanna Wittckind Costa, Bárbara Souza da Cattani, Shanda Aparecida Arbo, Marcelo Dutra Garcia, Solange Cristina Garcia, Cassia Virginia Volpato, Nadia Maria Schapoval, Elfrides Eva Scherman Steppe, Martin |
dc.subject.por.fl_str_mv |
Farmácia Fosfato de sitagliptina Vildagliptina Citotoxicidade Estresse oxidativo |
topic |
Farmácia Fosfato de sitagliptina Vildagliptina Citotoxicidade Estresse oxidativo |
description |
Background: The presence of impurities in some drugs may compromise the safety and efficacy of the patient’s treatment. Therefore, establishing of the biological safety of the impurities is essential. Diabetic patients are predisposed to tissue damage due to an increased oxidative stress process; and drug impurities may contribute to these toxic effects. In this context, the aim of this work was to study the toxicity, in 3 T3 cells, of the antidiabetic agents sitagliptin, vildagliptin, and their two main impurities of synthesis (S1 and S2; V1 and V2, respectively). Methods: MTT reduction and neutral red uptake assays were performed in cytotoxicity tests. In addition, DNA damage (measured by comet assay), intracellular free radicals (by DCF), NO production, and mitochondrial membrane potential (ΔψM) were evaluated. Results: Cytotoxicity was observed for impurity V2. Free radicals generation was found at 1000 μM of sitagliptin and 10 μM of both vildagliptin impurities (V1 and V2). A decrease in NO production was observed for all vildagliptin concentrations. No alterations were observed in ΔψM or DNA damage at the tested concentrations. Conclusions: This study demonstrated that the presence of impurities might increase the cytotoxicity and oxidative stress of the pharmaceutical formulations at the concentrations studied. |
publishDate |
2019 |
dc.date.issued.fl_str_mv |
2019 |
dc.date.accessioned.fl_str_mv |
2020-02-15T04:20:24Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/205991 |
dc.identifier.issn.pt_BR.fl_str_mv |
2050-6511 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001112186 |
identifier_str_mv |
2050-6511 001112186 |
url |
http://hdl.handle.net/10183/205991 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
BMC pharmacology and toxicology. London. Vol. 20, Supl. 1 (2019), 82, [9 p.] |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/205991/2/001112186.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/205991/1/001112186.pdf |
bitstream.checksum.fl_str_mv |
25e873f075c0b74c77ccaa7e382cd44c 126134e4a541d8a3ee8e1bc6fd2258a7 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447708288155648 |